What is a requirement for patients using Accutane and its generics?

Patients using Accutane (isotretinoin) and its generics are required to be enrolled in the iPledge program. This program was established to manage the risks associated with isotretinoin, particularly the risk of teratogenicity (causing birth defects) when taken during pregnancy. Enrollment in the iPledge program ensures that patients understand the potential side effects and comply with necessary precautions, such as using effective contraception if they are of childbearing potential.

The iPledge program involves patients, healthcare providers, and pharmacists, ensuring that appropriate education, pregnancy testing, and contraceptive measures are followed. Only enrolled patients can receive a prescription for isotretinoin, and this requirement is critical for monitoring and minimizing the risks associated with the medication. Thus, this answer accurately reflects the safety protocols in place for isotretinoin therapy.